Research Article
Coronary heart disease risk factors and atherosclerosis in young people

C. Alex McMahan, Samuel S. Gidding and Henry C. McGill

Journal of Clinical Lipidology, 2008, 2(3), 118-126. DOI: 10.1016/j.jacl.2008.02.006

Abstract

Atherosclerosis begins in childhood or adolescence and progresses during the young adult years to cause clinical coronary heart disease (CHD) in middle-aged and older individuals. This article reviews evidence regarding the association of the major established CHD risk factors with atherosclerosis in adolescents and young adults, with emphasis on the findings of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Age, non-high-density lipoprotein cholesterol concentration, smoking, hypertension, obesity, and hyperglycemia are positively associated with atherosclerotic lesions, whereas female gender and high-density lipoprotein cholesterol concentration are negatively associated with lesions. The PDAY study developed a risk score that provides a weighted summary of the risk factor effects on advanced atherosclerosis. Although developed to predict advanced atherosclerotic lesions, the risk score is also associated with all stages of lesion severity, including the transition from normal tissue to the earliest anatomically detectable lesion. Application of the PDAY risk score to data from longitudinal studies of risk factors in young adults shows that early measurement of risk factors predicts atherosclerosis assessed noninvasively up to 15 years later, and that subsequent change in risk score during the 15-year interval also predicts atherosclerosis. These findings provide strong support for maintaining a low lifetime risk and for focusing on preventing atherosclerosis as the most effective way to prevent CHD. Risk-factor control beginning in the late teenage years will retard development of the earliest stage of atherosclerosis and its progression, and will reduce or delay occurrence of CHD.

ASCI-ID: 2746-25

View Fulltext

Similar Articles


High-density lipoprotein, sphingosine 1-phosphate, and atherosclerosis

Journal of Clinical Lipidology, 2008, 2(1), 4-11. DOI: 10.1016/j.jacl.2007.11.002

Getting the word out: Teaching middle-school children about cardiovascular disease

Journal of Clinical Lipidology, 2008, 2(3), 179-188. DOI: 10.1016/j.jacl.2008.03.004

Flushing and the HDL-C response to extended-release niacin

Journal of Clinical Lipidology, 2008, 2(4), 285-288. DOI: 10.1016/j.jacl.2008.05.002

Medical management of patients before the incidence of a cardiovascular event

Journal of Clinical Lipidology, 2009, 3(5), 315-321. DOI: 10.1016/j.jacl.2009.08.002

Prevention of atherosclerosis with low-density lipoprotein cholesterol lowering-lipoprotein changes and interactions: the SANDS study

Journal of Clinical Lipidology, 2009, 3(5), 322-331. DOI: 10.1016/j.jacl.2009.09.001

High plasma high-density lipoprotein levels, very low cardiovascular risk profile, and subclinical carotid atherosclerosis in postmenopausal women

Journal of Clinical Lipidology, 2009, 3(5), 345-350. DOI: 10.1016/j.jacl.2009.08.003

Atherosclerosis in a managed care plan: hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring

Journal of Clinical Lipidology, 2009, 3(6), 385-392. DOI: 10.1016/j.jacl.2009.10.004

High-density lipoproteins: Marker of cardiovascular risk and therapeutic target

Journal of Clinical Lipidology, 2010, 4(5), 359-364. DOI: 10.1016/j.jacl.2010.08.002

Functions of cholesterol ester transfer protein and relationship to coronary artery disease risk

Journal of Clinical Lipidology, 2010, 4(5), 389-393. DOI: 10.1016/j.jacl.2010.08.006

Update on CETP inhibition

Journal of Clinical Lipidology, 2010, 4(5), 394-398. DOI: 10.1016/j.jacl.2010.08.003

Emerging high-density lipoprotein infusion therapies: Fulfilling the promise of epidemiology?

Journal of Clinical Lipidology, 2010, 4(5), 399-404. DOI: 10.1016/j.jacl.2010.08.018

Associations among smoking status, lifestyle and lipoprotein subclasses

Journal of Clinical Lipidology, 2010, 4(6), 522-530. DOI: 10.1016/j.jacl.2010.09.003

Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease

Journal of Clinical Lipidology, 2011, 5(3), 141-151. DOI: 10.1016/j.jacl.2011.02.003

Carotid intima-media thickness for the practicing lipidologist

Journal of Clinical Lipidology, 2010, 4(1), 24-35. DOI: 10.1016/j.jacl.2009.11.004

Impact of lipid profile and high blood pressure on endothelial damage

Journal of Clinical Lipidology, 2011, 5(6), 460-466. DOI: 10.1016/j.jacl.2011.06.005

Effect of Aggressive Cardiovascular Risk Factor Treatment on Progression of Carotid Intima-Media Thickness: Experience of an Atherosclerosis Center

Journal of Clinical Lipidology, 2012, 6(3), 262-263. DOI: 10.1016/j.jacl.2012.04.027

Serum apolipoprotein A-V in patients with coronary artery disease and its association with triglyceride

Journal of Clinical Lipidology, 2012, 6(5), 462-468. DOI: 10.1016/j.jacl.2012.02.004

Relationships between alcohol intake and atherogenic indices in women

Journal of Clinical Lipidology, 2013, 7(5), 454-462. DOI: 10.1016/j.jacl.2013.03.009

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia

Journal of Clinical Lipidology, 2013, 7(6), 561-565. DOI: 10.1016/j.jacl.2013.10.001

A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy

Journal of Clinical Lipidology, 2014, 8(2), 223-230. DOI: 10.1016/j.jacl.2013.11.005

Prolonged combination lipid therapy is associated with reduced carotid intima-media thickness: A case-control study of the 20-year Familial Atherosclerosis Treatment - Observational Study (FATS-OS)

Journal of Clinical Lipidology, 2014, 8(5), 489-493. DOI: 10.1016/j.jacl.2014.07.004

Efficacy of simvastatin therapy in attainment of LDL-C and TG goal levels in patients with type 2 diabetic dyslipidemia

Journal of Clinical Lipidology, 2008, 2(1), 12-18. DOI: 10.1016/j.jacl.2007.12.001

Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states

Journal of Clinical Lipidology, 2008, 2(4), 237-247. DOI: 10.1016/j.jacl.2008.06.002

High levels of urinary F2-isoprostanes predict cardiovascular mortality in postmenopausal women

Journal of Clinical Lipidology, 2008, 2(4), 298-303. DOI: 1016/j.jacl.2008.06.004

“Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events

Journal of Clinical Lipidology, 2010, 4(2), 89-98. DOI: 10.1016/j.jacl.2010.02.005

Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing

Journal of Clinical Lipidology, 2010, 4(2), 120-125. DOI: 10.1016/j.jacl.2010.02.001

Loss of early gains in low-density lipoprotein cholesterol goal attainment among high-risk patients

Journal of Clinical Lipidology, 2010, 4(2), 126-132. DOI: 10.1016/j.jacl.2010.01.007

Ezetimibe/simvastatin 10/20 mg versus simvastatin 40 mg in coronary heart disease patients

Journal of Clinical Lipidology, 2010, 4(4), 272-278. DOI: 10.1016/j.jacl.2010.05.002

Differences in lipoprotein particle subclass distribution for Japanese Americans in Hawaii and Japanese in Japan: The INTERLIPID Study

Journal of Clinical Lipidology, 2011, 5(1), 30-36. DOI: 10.1016/j.jacl.2010.11.007

Fatty acids in cardiovascular health and disease: A comprehensive update

Journal of Clinical Lipidology, 2012, 6(3), 216-234. DOI: 10.1016/j.jacl.2012.04.077

A meta-analysis of randomized controlled trials that compare the lipid effects of beef versus poultry and/or fish consumption

Journal of Clinical Lipidology, 2012, 6(4), 352-361. DOI: 10.1016/j.jacl.2012.01.001

Risk of coronary heart disease is associated with triglycerides and high-density lipoprotein cholesterol in women and non-high-density lipoprotein cholesterol in men

Journal of Clinical Lipidology, 2012, 6(4), 374-381. DOI: 10.1016/j.jacl.2012.02.011

Treatment options for the management of hypertriglyceridemia: Strategies based on the best-available evidence

Journal of Clinical Lipidology, 2012, 6(5), 413-426. DOI: 10.1016/j.jacl.2012.04.003

Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults

Journal of Clinical Lipidology, 2014, 8(1), 86-93. DOI: 10.1016/j.jacl.2013.11.001

Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study

Journal of Clinical Lipidology, 2014, 8(3), 279-286. DOI: 10.1016/j.jacl.2014.02.002

Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: A controlled trial

Journal of Clinical Lipidology, 2014, 8(1), 126-133. DOI: 10.1016/j.jacl.2013.09.007

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 - executive summary

Journal of Clinical Lipidology, 2014, 8(5), 473-488. DOI: 10.1016/j.jacl.2014.07.007

The population effects of the global cardiovascular risk model in United States Adults: Findings from the National Health and Nutrition Surveys, 2005-2006

Journal of Clinical Lipidology, 2011, 5(3), 166-172. DOI: 10.1016/j.jacl.2011.02.007

Age is positively associated with high-density lipoprotein cholesterol among African Americans in cross-sectional analysis: The Jackson Heart Study

Journal of Clinical Lipidology, 2011, 5(3), 173-178. DOI: 10.1016/j.jacl.2011.02.002

Pregnancy during adolescence has lasting adverse effects on blood lipids: A 10-year longitudinal study of black and white females

Journal of Clinical Lipidology, 2012, 6(2), 139-149. DOI: 10.1016/j.jacl.2011.12.004

Discordance between high non-HDL cholesterol and high LDL-cholesterol among US adults

Journal of Clinical Lipidology, 2014, 8(1), 86-93. DOI: 10.1016/j.jacl.2013.11.001

Risk of coronary heart disease associated with metabolic syndrome and its individual components in Iranian subjects: A matched cohort study

Journal of Clinical Lipidology, 2014, 8(3), 279-286. DOI: 10.1016/j.jacl.2014.02.002

Hypothyroidism as a risk factor for statin intolerance

Journal of Clinical Lipidology, 2014, 8(4), 401-407. DOI: 10.1016/j.jacl.2014.05.005

Comparison of cardiovascular disease risk associated with 3 lipid measures in Japanese adults

Journal of Clinical Lipidology, 2014, 8(5), 501-509. DOI: 10.1016/j.jacl.2014.06.005

Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?

Journal of Clinical Lipidology, 2010, 4(3), 152-155. DOI: 10.1016/j.jacl.2010.03.005

Prevalence of dyslipidemia in normoglycemic subjects with newly diagnosed high blood pressure in Abuja, Nigeria

Journal of Clinical Lipidology, 2009, 3(1), 51-56. DOI: 10.1016/j.jacl.2008.12.001

The population effects of the global cardiovascular risk model in United States Adults: Findings from the National Health and Nutrition Surveys, 2005-2006

Journal of Clinical Lipidology, 2011, 5(3), 166-172. DOI: 10.1016/j.jacl.2011.02.007

Smoking intensity and lipoprotein abnormalities in active smokers

Journal of Clinical Lipidology, 2009, 3(6), 372-378. DOI: 10.1016/j.jacl.2009.10.008

Biographical notes on Ancel Keys and Salim Yusuf: Origins and significance of the Seven Countries Study and the INTERHEART Study

Journal of Clinical Lipidology, 2011, 5(6), 434-440. DOI: 10.1016/j.jacl.2011.09.003

The relationship between subclinical atherosclerosis, non-high-density lipoprotein cholesterol, exercise, and diet among male participants of the PACC Project

Journal of Clinical Lipidology, 2012, 6(2), 174-179. DOI: 10.1016/j.jacl.2011.11.005

Apolipoproteins A-I, B, and C-III in young adult Cherokee with metabolic syndrome with or without type 2 diabetes

Journal of Clinical Lipidology, 2013, 7(1), 38-42. DOI: 10.1016/j.jacl.2012.06.007

Postprandial lipemia is not increased in patients with previous unprovoked venous thromboembolism

Journal of Clinical Lipidology, 2013, 7(1), 48-55. DOI: 10.1016/j.jacl.2012.06.001

Dyslipidemia and associated risk factors in a resettlement colony of Delhi

Journal of Clinical Lipidology, 2013, 7(6), 653-660. DOI: 10.1016/j.jacl.2013.06.003

Benefits associated with achieving optimal risk factor levels for the primary prevention of cardiovascular disease in older men

Journal of Clinical Lipidology, 2012, 6(1), 58-65. DOI: 10.1016/j.jacl.2011.10.019

Exercise-Promoting healthy lifestyles in children and adolescents

Journal of Clinical Lipidology, 2008, 2(3), 162-168. DOI: 10.1016/j.jacl.2008.03.001